Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms (Q33359732)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

James Bruce Bussel

8

object named as

James B Bussel

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Nichola Cooper

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nancy M Heddle

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Masja Haas

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Marion E Reid

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Martin L Lesser

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Howard B Fleit

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

B M R Woloski

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

124

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

511-518

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

In vivo modulation of cytokine synthesis by intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

FcγRI blockade and modulation for immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

Correlation of platelet Fc gammaRIIA polymorphism in refractory idiopathic (immune) thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

Fc-depleted vs intact intravenous immunoglobulin in chronic ITP

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04804.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2004.04804.X

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33359732&oldid=1697593257"